Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Study of B2036-PEG in Acromegaly - Long Term Study With B2036-PEG -

NCT00143416 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00143416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Study of B2036-PEG in Acromegaly - Long Term Study With B2036-PEG -
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
July 31, 2007
Enrollment
16
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly